De Duve Institute AISBL

De Duve Institute AISBL is a research organisation in Bruxelles / Brussel, Belgium that has taken part in 9 EU-funded projects since 2009, receiving €3.3M in EU funding and leading 1 as coordinator.

EU funding received€3.3M
EU projects9
As coordinator1
Running now1
First EU project2009
Latest project2027
CountryBelgium
EU registration (PIC)997886240
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are De Duve Institute AISBL's own share of each project, not the project's full budget.

  • Horizon 2020€2.2M · 6 projects
  • Horizon Europe€577k · 1 project
  • FP7 (2007 to 2013)€490k · 2 projects

Projects

9 EU-funded projects, newest first. De Duve Institute AISBL led 1 of them as coordinator. Each links to the official record.

  • TIE2getherPartner

    Next-generation therapeutics for vascular diseases

    Horizon Europe · 2027–2031 · Project on CORDIS ↗

    €577ktheir share
  • INCITEPartner

    Immune Niches for Cancer ImmunoTherapy Enhancement

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €382ktheir share
  • TheraLymphPartner

    Gene Therapy to restore lymphatic flow lymphedema

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €608ktheir share
  • V.A. CureCoordinator

    A multidisciplinary approach towards sustainable improvement in rare diseases care uniting Europe's top class vascular research to find new treatment strategies for vascular anomalies

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €513ktheir share
  • IMMUcanPartner

    Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts

    Horizon 2020 · 2019–2026 · Project on CORDIS ↗

  • Pan3DPPartner

    3D bioprinting of pancreatic tissue for biomedical research

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €421ktheir share
  • MESI-STRATPartner

    Systems Medicine of Metabolic-Signaling Networks: A New Concept for Breast Cancer Patient Stratification

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €289ktheir share
  • PIMT and signalingPartner

    Interaction between the protein repair enzyme L-isoaspartyl methyltransferase and insulin/IGF-1 signaling in mice and worms

    FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

    €100ktheir share
  • BOLDPartner

    Biology of Liver and Pancreatic Development and Disease

    FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

    €390ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • additive manufacturing
  • breast cancer
  • cardiovascular diseases
  • cell biology
  • chemical sciences
  • databases
  • developmental biology
  • diabetes
  • drug discovery
  • employment
  • enzymes
  • epigenetics
  • gene therapy
  • glaucoma

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime